no statement of use filed
on 23 May 2022
Last Applicant/ Owned by
3838 Tamiami Trail North, Suite 310
Naples
FL
34103
Serial Number
87835171 filed on 15th Mar 2018
Registration Number
N/A
Correspondent Address
Anessa O. Kramer
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Genetic mapping for scientific purposes; gene sequencing for scientific purposes; molecular sequencing for scientific purposes; scientific study and analysis in the field of cancer; clinical research, namely, study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; Read More
Medical diagnostic testing services in the field of human disease and human medical conditions; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, and human medical conditions, medical diagnostic testing services, medical testing for diagnostic or treatment purposes; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing services, and medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes for the detection of cancer; medical testing for diagnostic or treatment purposes for the detection of genetic information pertaining to human disease; medical diagnostic testing to aid in diagnosis, prognosis and therapy selection; providing information to others in the fields of pathology, medical diagnostic testing and oncology testing, human disease and human medical conditions
Genetic mapping for scientific purposes; gene sequencing for scientific purposes; molecular sequencing for scientific purposes; scientific study and analysis in the field of cancer; clinical research, namely, study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells, and cancer; providing medical research and scientific research information to others in the fields of oncology, pathology and gene sequencing, molecular sequencing, cancer study and analysis, clinical study and testing of cells scientific testing and research services and clinical scientific testing; providing an internet website portal featuring gene sequencing for scientific purposes, molecular sequencing for scientific purposes, cancer study and analysis, clinical study and testing of cells; scientific and medical research information in the fields of scientific testing and research services, medical research services, and clinical scientific testing; providing cloud-based scientific and medical research information to others in the field of scientific testing and research services, medical research services, and clinical scientific testing; providing temporary use of online non-downloadable software for analysis of medical test results; providing temporary use of online non-downloadable software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to such testing and analysis; software as a service (SAAS) services featuring software for analysis of medical test results; providing on-line non-downloadable computer software for enhancement of analysis, research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information pertaining to testing and analysis; providing medical research and scientific research information in the field of oncology; genetic testing, rna testing and sequencing for scientific purposes; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; medical laboratory services, namely, clinical laboratory services and oncology reference laboratory services, providing medical research and scientific research information and reports, to others in the field of pathology, diagnostic testing, oncology testing; providing an interactive website featuring information and reports in the field of scientific research in pathology, diagnostic testing, oncology testing; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; medical and scientific research, namely, conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; medical laboratory services, namely, medical oncology reference laboratory services
Educational services, namely, conducting in-person and online seminars, webinars, lectures, presentations, classes and workshops in the field of oncology, medical testing, and diagnostic testing
No 87835171
No Service Mark
No 271659509116
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 13th Jun 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 13th Jun 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 13th Jun 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd May 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| 23rd May 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 13th Oct 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 12th Oct 2021 | SOU EXTENSION 5 GRANTED |
| 06th Oct 2021 | SOU TEAS EXTENSION RECEIVED |
| 06th Oct 2021 | SOU EXTENSION 5 FILED |
| 16th Apr 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
